{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T21:20:07Z","timestamp":1773436807631,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1016\/s0002-9394(02)01982-7","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T09:05:18Z","timestamp":1046768718000},"page":"297-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Topical tacrolimus treatment of atopic eyelid disease"],"prefix":"10.1016","volume":"135","author":[{"given":"Sarah M","family":"Rikkers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary N","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail E","family":"Drayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz K","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark F","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefani","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(02)01982-7_BIB1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II","volume":"106","author":"Bielory","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB2","series-title":"Ocular infection and immunity","first-page":"376","article-title":"Atopic keratoconjunctivitis","author":"Liesegang","year":"1996"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archderm.135.5.574","article-title":"Tacrolimus","volume":"135","author":"Ruzicka","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199709183371203","article-title":"A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group","volume":"337","author":"Ruzicka","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB5","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1067\/mjd.2001.109810","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients","volume":"44","author":"Hanifin","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB6","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients","volume":"44","author":"Soter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-2001-18665","article-title":"0,1% FK 506-Salbe\u2013Eine neue therapeutische Option bei der atopischen Blepharitis. Klinische Studie an 14 Patienten","volume":"218","author":"Mayer","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"Suppl","key":"10.1016\/S0002-9394(02)01982-7_BIB8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derma Venereol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1067\/mai.2001.112942","article-title":"Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis","volume":"107","author":"Wollenberg","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1998.00323.x","article-title":"Tacrolimus ointment does not affect collagen synthesis","volume":"111","author":"Reitamo","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mai.2002.121831","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0002-9394(02)01982-7_BIB12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1067\/mai.2002.121832","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"J Allergy Clin Immunol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402019827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402019827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:31:00Z","timestamp":1757593860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402019827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0002939402019827"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(02)01982-7","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical tacrolimus treatment of atopic eyelid disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(02)01982-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}